October 12, 2010
FDA Warning Letter to Hormonal Health, LLC
On October 12, 2010, the U.S. Food and Drug Administration (FDA) sent a warning letter to Hormonal Health, LLC, for marketing non-prescription “chelation” products
as treatments for a range of disorders including autism. The FDA warning to the public noted that the companies’ claims of health benefits for specific conditions have
not been proven. No chelation agents have been approved for any use without a prescription. The products have been marketed as “dietary supplements” in a
variety of dosages and forms, including suppositories, capsules, liquid drops, sprays and clay baths.
|
To download the file in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will
launch the file so that you can see the document and/or print it.